Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) in advanced non-small cell lung cancer (NSCLC) involving the CNS. Article

Web of Science: 000680263501308

Cited authors

  • Weiner RS, Morgan LR, Ware M, Mahmood T, Gordon C, Bhandari M, Rodgers A, Matrana M, Cosgriff TM, Friedlander P, Zou JJ

Publication date

  • 2021

Published in


International Standard Serial Number (ISSN)

  • 0008-5472

Number of pages

  • 2


  • 81


  • 13